Clinical Microbiology Newsletter
Volume 32, Issue 2 , Pages 9-15, 15 January 2010

The Best Practices for Screening, Monitoring, and Diagnosis of Cytomegalovirus Disease, Part II

  • Tiziana Lazzarotto, Ph.D. (Head of the Laboratory of Virology, Operative Unit of Clinical Microbiology)

      Affiliations

    • Corresponding Author InformationMailing address: T. Lazzarotto, Ph.D., U.O. Microbiologia, Policlinico S. Orsola-Malpighi, Via Massarenti n. 9, 40138 Bologna, Italy. Tel.: +39.051.636.3360. Fax: +39.051.307397

Department of Haematology, Oncology and Laboratory Medicine, St. Orsola Malpighi General Hospital, University of Bologna, Bologna, Italy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Editor's Note: Part I of this article was published in the January 1, 2010 issue of CMN (Vol. 32, No. 1).

PII: S0196-4399(09)00062-2

doi:10.1016/j.clinmicnews.2009.12.004

Clinical Microbiology Newsletter
Volume 32, Issue 2 , Pages 9-15, 15 January 2010